Outside clinical trials, medication effectiveness often declines because of cost, adherence issues, side effects, discontinuation, and inadequate follow-up
Nausea is the most commonly reported early side effect and tends to ease within the first month as the body adjusts
L-BHB supports extended energy availability and metabolic signaling
Like Ozempic, Wegovys active ingredient is semaglutide, but it is prescribed at a higher dose for chronic weight management in obese and certain overweight populations
The inactive structure aligns with the dual functional hypothesis of the ECD through which, on one hand, peptide binding and activation is mediated when the ligand is present, while on the other, the receptor is negatively regulated in its peptide-free state
If any unusual or severe side effects happen, we stop the peptide therapy and seek medical advice right away